Patient Name : Mr.

RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM

Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 10:21AM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 11:39AM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

DEPARTMENT OF HAEMATOLOGY
VISIT HEALTH - VH00MUFG BELOW 35 MALE CREDIT PAN INDIA FY24-25

Test Name Result Unit Bio. Ref. Interval Method

COMPLETE BLOOD COUNT (CBC) , WHOLE BLOOD EDTA
HAEMOGLOBIN 15.5 g/dL 13-17 Spectrophotometer
PCV 46.60 % 40-50 Electronic pulse &
Calculation
RBC COUNT 4.92 Million/cu.mm 4.5-5.5 Electrical Impedence
MCV 95 fL 83-101 Calculated
MCH 31.5 pg 27-32 Calculated
MCHC 33.3 g/dL 31.5-34.5 Calculated
R.D.W 14.7 % 11.6-14 Calculated
TOTAL LEUCOCYTE COUNT (TLC) 8,500 cells/cu.mm 4000-10000 Electrical Impedance
DIFFERENTIAL LEUCOCYTIC COUNT (DLC)
NEUTROPHILS 45 % 40-80 Electrical Impedance
LYMPHOCYTES 48 % 20-40 Electrical Impedance
EOSINOPHILS 02 % 1-6 Electrical Impedance
MONOCYTES 05 % 2-10 Electrical Impedance
BASOPHILS 00 % <1-2 Electrical Impedance
CORRECTED TLC 8,500 Cells/cu.mm Calculated
ABSOLUTE LEUCOCYTE COUNT
NEUTROPHILS 3825 Cells/cu.mm 2000-7000 Calculated
LYMPHOCYTES 4080 Cells/cu.mm 1000-3000 Calculated
EOSINOPHILS 170 Cells/cu.mm 20-500 Calculated
MONOCYTES 425 Cells/cu.mm 200-1000 Calculated
Neutrophil lymphocyte ratio (NLR) 0.94 0.78- 3.53 Calculated
PLATELET COUNT 260000 cells/cu.mm 150000-410000 Electrical impedence

Page 1 of 15

SIN No:BED240244229
Patient Name : Mr.RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM
Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 10:25AM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 10:47AM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

DEPARTMENT OF BIOCHEMISTRY
VISIT HEALTH - VH00MUFG BELOW 35 MALE CREDIT PAN INDIA FY24-25

Test Name Result Unit Bio. Ref. Interval Method

GLUCOSE, FASTING , NAF PLASMA 86 mg/dL 70-100 GOD - POD

Comment:
As per American Diabetes Guidelines, 2023
Fasting Glucose Values in mg/dL Interpretation
70-100 mg/dL Normal
100-125 mg/dL Prediabetes
≥126 mg/dL Diabetes
<70 mg/dL Hypoglycemia
Note:
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL and/or a random / 2 hr post glucose value of
> or = 200 mg/dL on at least 2 occasions.
2. Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis & is considered critical.

Page 2 of 15

SIN No:PLF02210925
Patient Name : Mr.RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM
Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 01:57PM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 02:59PM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

DEPARTMENT OF BIOCHEMISTRY
VISIT HEALTH - VH00MUFG BELOW 35 MALE CREDIT PAN INDIA FY24-25

Test Name Result Unit Bio. Ref. Interval Method

HBA1C (GLYCATED HEMOGLOBIN) , WHOLE BLOOD EDTA
HBA1C, GLYCATED HEMOGLOBIN 5.4 % HPLC
ESTIMATED AVERAGE GLUCOSE 108 mg/dL Calculated
(eAG)
Comment:
Reference Range as per American Diabetes Association (ADA) 2023 Guidelines:
REFERENCE GROUP HBA1C %
NON DIABETIC <5.7
PREDIABETES 5.7 – 6.4
DIABETES ≥ 6.5
DIABETICS
EXCELLENT CONTROL 6–7
FAIR TO GOOD CONTROL 7–8
UNSATISFACTORY CONTROL 8 – 10
POOR CONTROL >10
Note: Dietary preparation or fasting is not required.
1. HbA1C is recommended by American Diabetes Association for Diagnosing Diabetes and monitoring Glycemic
Control by American Diabetes Association guidelines 2023.
2. Trends in HbA1C values is a better indicator of Glycemic control than a single test.
3. Low HbA1C in Non-Diabetic patients are associated with Anemia (Iron Deficiency/Hemolytic), Liver Disorders, Chronic Kidney Disease. Clinical Correlation is
advised in interpretation of low Values.
4. Falsely low HbA1c (below 4%) may be observed in patients with clinical conditions that shorten erythrocyte life span or decrease mean erythrocyte age. HbA1c may
not accurately reflect glycemic control when clinical conditions that affect erythrocyte survival are present.
5. In cases of Interference of Hemoglobin variants in HbA1C, alternative methods (Fructosamine) estimation is recommended for Glycemic Control
A: HbF >25%
B: Homozygous Hemoglobinopathy.
(Hb Electrophoresis is recommended method for detection of Hemoglobinopathy)

Page 3 of 15

SIN No:EDT240093819
Patient Name : Mr.RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM
Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 01:57PM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 03:01PM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

DEPARTMENT OF BIOCHEMISTRY
VISIT HEALTH - VH00MUFG BELOW 35 MALE CREDIT PAN INDIA FY24-25

Test Name Result Unit Bio. Ref. Interval Method

LDL CHOLESTEROL - (DIRECT LDL) , 136.30 mg/dL <100 CHE/CHO/POD &
SERUM Catalase

Page 4 of 15

SIN No:SE04841828
Patient Name : Mr.RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM
Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 10:25AM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 01:30PM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

DEPARTMENT OF BIOCHEMISTRY
VISIT HEALTH - VH00MUFG BELOW 35 MALE CREDIT PAN INDIA FY24-25

Test Name Result Unit Bio. Ref. Interval Method

LIVER FUNCTION TEST (LFT) WITH GGT , SERUM
BILIRUBIN, TOTAL 0.60 mg/dL 0.1-1.2 Azobilirubin
BILIRUBIN CONJUGATED (DIRECT) 0.20 mg/dL 0.1-0.4 DIAZO DYE
BILIRUBIN (INDIRECT) 0.40 mg/dL 0.0-1.1 Dual Wavelength
ALANINE AMINOTRANSFERASE 14 U/L 4-44 JSCC
(ALT/SGPT)
ASPARTATE AMINOTRANSFERASE 18.0 U/L 8-38 JSCC
(AST/SGOT)
AST (SGOT) / ALT (SGPT) RATIO (DE 1.3 <1.15 Calculated
RITIS)
ALKALINE PHOSPHATASE 51.00 U/L 32-111 IFCC
PROTEIN, TOTAL 7.30 g/dL 6.7-8.3 BIURET
ALBUMIN 4.70 g/dL 3.8-5.0 BROMOCRESOL
GREEN
GLOBULIN 2.60 g/dL 2.0-3.5 Calculated
A/G RATIO 1.81 0.9-2.0 Calculated
GAMMA GLUTAMYL 16.00 U/L 16-73 Glycylglycine Kinetic
TRANSPEPTIDASE (GGT) method
Comment:
LFT results reflect different aspects of the health of the liver, i.e., hepatocyte integrity (AST & ALT), synthesis and secretion of
bile (Bilirubin, ALP), cholestasis (ALP, GGT), protein synthesis (Albumin) Common patterns seen:
1. Hepatocellular Injury:
*AST – Elevated levels can be seen. However, it is not specific to liver and can be raised in cardiac and skeletal
injuries. *ALT – Elevated levels indicate hepatocellular damage. It is considered to be most specific lab test for hepatocellular
injury. Values also correlate well with increasing BMI. Disproportionate increase in AST, ALT compared with ALP. AST: ALT
(ratio) – In case of hepatocellular injury AST: ALT > 1In Alcoholic Liver Disease AST: ALT usually >2. This ratio is also seen to
be increased in NAFLD, Wilsons’s diseases, Cirrhosis, but the increase is usually not >2.
2. Cholestatic Pattern:
*ALP – Disproportionate increase in ALP compared with AST, ALT. ALP elevation also seen in pregnancy, impacted by age
and sex. *Bilirubin elevated- predominantly direct , To establish the hepatic origin correlation with elevated GGT helps.
Page 5 of 15

SIN No:SE04841827
Patient Name : Mr.RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM
Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 10:25AM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 01:30PM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

DEPARTMENT OF BIOCHEMISTRY
VISIT HEALTH - VH00MUFG BELOW 35 MALE CREDIT PAN INDIA FY24-25
3. Synthetic function impairment:
*Albumin- Liver disease reduces albumin levels, Correlation with PT (Prothrombin Time) helps.
4. Associated tests for assessment of liver fibrosis - Fibrosis-4 and APRI Index.

Page 6 of 15

SIN No:SE04841827
Patient Name : Mr.RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM
Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 10:25AM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 01:30PM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

DEPARTMENT OF BIOCHEMISTRY
VISIT HEALTH - VH00MUFG BELOW 35 MALE CREDIT PAN INDIA FY24-25

Test Name Result Unit Bio. Ref. Interval Method

UREA. , SERUM 16.48 mg/dL 19-43 Urease
BLOOD UREA NITROGEN , SERUM 7.7 mg/dL 8.0 - 23.0 Calculated

Test Name Result Unit Bio. Ref. Interval Method

TOTAL CHOLESTEROL , SERUM 197 mg/dL <200 CHE/CHO/POD

Test Name Result Unit Bio. Ref. Interval Method

CREATININE , SERUM 0.87 mg/dL 0.6-1.1 ENZYMATIC METHOD

Test Name Result Unit Bio. Ref. Interval Method

HDL CHOLESTEROL , SERUM 36 mg/dL >40 CHE/CHO/POD

Comments:-
HDL contains 20 to 30 % of total serum cholesterol. Low HDL cholesterol is a significant risk factor for coronary artery disease
even if total cholesterol is normal.
Uncontrolled diabetes.
Hepatocellular disease.
Chronic renal failure.
Cholestasis.
Abetaliporoteinemia.
Genetic abnormalities involving cholesterol metabolism

Page 7 of 15

SIN No:SE04841827
Patient Name : Mr.RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM
Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 01:57PM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 03:01PM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

DEPARTMENT OF BIOCHEMISTRY
VISIT HEALTH - VH00MUFG BELOW 35 MALE CREDIT PAN INDIA FY24-25

Test Name Result Unit Bio. Ref. Interval Method

IRON , SERUM 96.6 µg/dL 49-181 Ferene

Comments:-
Iron exists in the body as haemoglobin in the circulating red cells, iron containing proteins such as myoglobin & cytochromes.
Serum, Iron levels are useful in the differential diagnosis of anemias, diagnosis of hemochromatosis & sideroblastic anemia. Iron
levels are useful in monitoring response to iron therapy.

Page 8 of 15

SIN No:SE04841828
Patient Name : Mr.RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM
Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 10:25AM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 01:04PM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

DEPARTMENT OF BIOCHEMISTRY
VISIT HEALTH - VH00MUFG BELOW 35 MALE CREDIT PAN INDIA FY24-25

Test Name Result Unit Bio. Ref. Interval Method

TRIGLYCERIDES , SERUM 129 mg/dL <150

Page 9 of 15

SIN No:SE04841827
Patient Name : Mr.RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM
Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 10:25AM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 01:30PM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

DEPARTMENT OF BIOCHEMISTRY
VISIT HEALTH - VH00MUFG BELOW 35 MALE CREDIT PAN INDIA FY24-25

Test Name Result Unit Bio. Ref. Interval Method

URIC ACID , SERUM 5.00 mg/dL 4.0-7.0 URICASE

Comments:-
Uric acid is an end product of purine catabolism. Most uric acid is synthesised in the liver & from the intestine.Two thirds of uric
acid is excreted by the kidneys.

Page 10 of 15

SIN No:SE04841827
Patient Name : Mr.RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM
Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 01:57PM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 02:50PM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

DEPARTMENT OF IMMUNOLOGY
VISIT HEALTH - VH00MUFG BELOW 35 MALE CREDIT PAN INDIA FY24-25

Test Name Result Unit Bio. Ref. Interval Method

THYROID STIMULATING HORMONE 1.694 µIU/mL 0.34-5.60 CLIA
(TSH) , SERUM
Comment:
TSH is a glycoprotein hormone secreted by the anterior pituitary. TSH is a labile hormone & is secreted in a pulsatile manner
throughout the day and is subject to several non-thyroidal pituitary influences.Significant variations in TSH can occur with
circadian rhythm, hormonal status, stress, sleep deprivation, caloric intake, medication & circulating antibodies.
It is important to confirm any TSH abnormality in a fresh specimen drawn after ~ 3 weeks before assigning a diagnosis, as
the cause of an isolated TSH abnormality.
Bio Ref Range for TSH in uIU/ml (As per
For pregnant females
American Thyroid Association)
First trimester 0.1 - 2.5
Second trimester 0.2 – 3.0
Third trimester 0.3 – 3.0

Page 11 of 15

SIN No:SPL24145669
Patient Name : Mr.RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM
Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 01:57PM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 03:14PM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

DEPARTMENT OF IMMUNOLOGY
VISIT HEALTH - VH00MUFG BELOW 35 MALE CREDIT PAN INDIA FY24-25

Test Name Result Unit Bio. Ref. Interval Method

VITAMIN D (25 - OH VITAMIN D) , 23.22 ng/mL CLIA
SERUM

Comment:
BIOLOGICAL REFERENCE RANGES
VITAMIN D STATUS VITAMIN D 25 HYDROXY (ng/mL)
DEFICIENCY <10
INSUFFICIENCY 10 – 30
SUFFICIENCY 30 – 100
TOXICITY >100

The biological function of Vitamin D is to maintain normal levels of calcium and phosphorus absorption. 25-Hydroxy vitamin D is
the storage form of vitamin D. Vitamin D assists in maintaining bone health by facilitating calcium absorption. Vitamin D deficiency
can also cause osteomalacia, which frequently affects elderly patients.
Vitamin D Total levels are composed of two components namely 25-Hydroxy Vitamin D2 and 25-Hydroxy Vitamin D3 both of
which are converted into active forms. Vitamin D2 level corresponds with the exogenous dietary intake of Vitamin D rich foods as
well as supplements. Vitamin D3 level corresponds with endogenous production as well as exogenous diet and supplements.
Vitamin D from sunshine on the skin or from dietary intake is converted predominantly by the liver into 25-hydroxy vitamin D,
which has a long half-life and is stored in the adipose tissue. The metabolically active form of vitamin D, 1,25-di-hydroxy vitamin
D, which has a short life, is then synthesized in the kidney as needed from circulating 25-hydroxy vitamin D. The reference interval
of greater than 30 ng/mL is a target value established by the Endocrine Society.
Decreased Levels:- Inadequate exposure to sunlight, Dietary deficiency, Vitamin D malabsorption, Severe Hepatocellular
disease., Drugs like Anticonvulsants, Nephrotic syndrome.
Increased levels:- Vitamin D intoxication.

Test Name Result Unit Bio. Ref. Interval Method

VITAMIN B12 , SERUM 104 pg/mL 120-914 CLIA

Comment:
Page 12 of 15

SIN No:SPL24145669
Patient Name : Mr.RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM
Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 01:57PM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 03:14PM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

DEPARTMENT OF IMMUNOLOGY
VISIT HEALTH - VH00MUFG BELOW 35 MALE CREDIT PAN INDIA FY24-25
Vitamin B12 deficiency frequently causes macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss
of proprioception, poor coordination, and affective behavioral changes. A significant increase in RBC MCV may be an important
indicator of vitamin B12 deficiency.
Patients taking vitamin B12 supplementation may have misleading results. A normal serum concentration of B12 does not rule out
tissue deficiency of vitamin B12 . The most sensitive test for B12 deficiency at the cellular level is the assay for MMA. If clinical
symptoms suggest deficiency, measurement of MMA and homocysteine should be considered, even if serum B12 concentrations
are normal.

Page 13 of 15

SIN No:SPL24145669
Patient Name : Mr.RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM
Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 12:38PM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 03:47PM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

DEPARTMENT OF CLINICAL PATHOLOGY

VISIT HEALTH - VH00MUFG BELOW 35 MALE CREDIT PAN INDIA FY24-25

Test Name Result Unit Bio. Ref. Interval Method

COMPLETE URINE EXAMINATION (CUE) , URINE
PHYSICAL EXAMINATION
COLOUR PALE YELLOW PALE YELLOW Visual
TRANSPARENCY CLEAR CLEAR Physical Measurement
pH 6.0 5-7.5 Double Indicator
SP. GRAVITY 1.010 1.002-1.030 Bromothymol Blue
BIOCHEMICAL EXAMINATION
URINE PROTEIN NEGATIVE NEGATIVE Protein Error Of
Indicator
GLUCOSE NEGATIVE NEGATIVE Glucose Oxidase
URINE BILIRUBIN NEGATIVE NEGATIVE Azo Coupling Reaction
URINE KETONES (RANDOM) NEGATIVE NEGATIVE Sodium Nitro Prusside
UROBILINOGEN NORMAL NORMAL Modifed Ehrlich
Reaction
NITRITE NEGATIVE NEGATIVE Diazotization
LEUCOCYTE ESTERASE NEGATIVE NEGATIVE Leucocyte Esterase
CENTRIFUGED SEDIMENT WET MOUNT AND MICROSCOPY
PUS CELLS 1-2 /hpf 0-5 Microscopy
EPITHELIAL CELLS 0-1 /hpf <10 Microscopy
RBC ABSENT /hpf 0-2 Microscopy
CASTS NIL 0-2 Hyaline Cast Microscopy
CRYSTALS ABSENT ABSENT Microscopy

Comment:
All urine samples are checked for adequacy and suitability before examination. All abnormal chemical examination are rechecked
and verified by manual methods. Microscopy findings are reported as an average of 10 high power fields.

*** End Of Report ***

Page 14 of 15

SIN No:UR2418761
Patient Name : Mr.RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM
Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 12:38PM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 03:47PM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

DEPARTMENT OF CLINICAL PATHOLOGY

VISIT HEALTH - VH00MUFG BELOW 35 MALE CREDIT PAN INDIA FY24-25

Page 15 of 15

SIN No:UR2418761
 Patient Name : Mr.RAVI DHOLPURIYA Collected : 05/Nov/2024 08:06AM
Age/Gender : 25 Y 5 M 21 D/M Received : 05/Nov/2024 12:38PM
UHID/MR No : SCHE.0000089113 Reported : 05/Nov/2024 03:47PM
Visit ID : SCHEOPV107565 Status : Final Report
Ref Doctor : Dr.SELF Sponsor Name : VISIT HEALTH PRIVATE LIMITED
Emp/Auth/TPA ID : 453809

TERMS AND CONDITIONS GOVERNING THIS REPORT

1. Reported results are for information and interpretation of the referring doctor or such other medical professionals,
who understandreporting units, reference ranges and limitation of technologies.Laboratories not be responsible for any
interpretation whatsoever.
2. It is presumed that the tests performed are, on the specimen / sample being to the patient named or identified and the
verifications of parrticulars have been confirmed by the patient or his / her representative at the point of generation of said specimen.
3. The reported results are restricted to the given specimen only. Results may vary from lab to lab and from time to time for the same
parameter for the same patient (within subject biological variation).
4. The patient details along with their results in certain cases like notifiable diseases and as per local regulatory requirements will be
communicated to the assigned regulatory bodies.
5. The patient samples can be used as part of internal quality control, test verification, data analysis purposes within the testing scope of
the laboratory.
6. This report is not valid for medico legal purposes. It is performed to facilitate medical diagnosis only.

SIN No:UR2418761
Patient Name : Mr. Ravi Dholpuriya Age/Gender : 25 Y/M

UHID/MR No. : SCHE.0000089113 OP Visit No : SCHEOPV107565

Sample Collected on : Reported on : 05-11-2024 09:13
LRN# : RAD2431730 Specimen :
Ref Doctor : SELF
Emp/Auth/TPA ID : 453809

DEPARTMENT OF RADIOLOGY

ULTRASOUND - WHOLE ABDOMEN

Liver : Normal in size, shape and echotexture. No obvious mass seen. IHBR appear normal.
Gall Bladder : Well-distended, no obvious calculus seen. Wall thickness is within normal limits.
CBD not dilated.
Pancreas: Normal in size and echopattern.
Spleen : Normal in size, echopattern
Kidneys : Both the kidneys are normal in size, shape and position.
Corticomedullary differentiation grossly maintained.
No obvious calculus/hydronephrosis seen.
RK : 10.4 x 4.5cm.
LK : 10.8 x 5.5 cm.
No obvious mass/collection seen at the time of scan.
No fluid seen in the peritoneal cavity.
Urinary bladder: Well distended with clear contents. Wall thickness is within normal limits.
Prostate: appears normal in size and echotexture. (Volume- 22.8 cc ).
IMPRESSION: ESSENTIALLY NORMAL WHOLE ABDOMEN.

Dr. DEEPIKA RAMESH SINGH

MBBS,DNB
Radiology